Home › Asset managers › Compare 2025-2026 › Invesco vs Brighthouse
Note on Brighthouse: its funds did not all vote the same way on 12.0% of the 120,248 ballot items it voted. Those items are not in the percentage above; the ones it shares with this pair are listed under “Split votes”.
Invesco 2025-2026 · Brighthouse 2025-2026 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 53,305 | 38,593 | 3,447 | 11,265 | 91.8% | 85.4% |
| Board proposals | 45,557 | 32,017 | 3,137 | 10,403 | 91.1% | 84.6% |
| E&S shareholder proposals | 173 | 0 | 0 | 173 | n/a | 40.9% |
| Other items | 7,575 | 6,576 | 310 | 689 | 95.5% | 91.7% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
10,403 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | Invesco | Brighthouse |
|---|---|---|---|---|---|---|
| AGILON HEALTH, INC. | March 17, 2026 | Approval of an amendment to the Company's Amended and Restated Certificate of Incorporation to effect a reverse stock split of the Company's common stock by a ratio of one-for-five to one-for-twenty-five, with the exact ratio to be set within this range by the Board of Directors in its sole discretion (without reducing the authorized number of shares of the Company's common stock) (the "Amendment Proposal"); and Capital Structure |
Board | For | FOR 1 fund |
Split 2 FOR, 1 ABSTAIN |
| AGILON HEALTH, INC. | June 2, 2026 | Approval, by advisory vote, of the compensation paid to the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 3 funds |
Split 2 FOR, 1 ABSTAIN |
| AGILON HEALTH, INC. | June 2, 2026 | Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. Audit-related |
Board | For | FOR 1 fund |
Split 2 FOR, 1 ABSTAIN |
| AGILYSYS, INC. | September 4, 2025 | Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers set forth in the attached Proxy Statement Say-on-Pay |
Board | For | FOR 11 funds |
Split 5 FOR, 1 ABSTAIN |
| AGILYSYS, INC. | September 4, 2025 | Election of Directors: Dana Jones Director Elections |
Board | For | FOR 7 funds |
Split 5 FOR, 1 ABSTAIN |
| AGILYSYS, INC. | September 4, 2025 | Election of Directors: Donald A. Colvin Director Elections |
Board | For | FOR 7 funds |
Split 5 FOR, 1 ABSTAIN |
| AGILYSYS, INC. | September 4, 2025 | Election of Directors: Jerry Jones Director Elections |
Board | For | FOR 7 funds |
Split 5 FOR, 1 ABSTAIN |
| AGILYSYS, INC. | September 4, 2025 | Election of Directors: John Mutch Director Elections |
Board | For | FOR 7 funds |
Split 5 FOR, 1 ABSTAIN |
| AGILYSYS, INC. | September 4, 2025 | Election of Directors: Lisa Pope Director Elections |
Board | For | FOR 7 funds |
Split 5 FOR, 1 ABSTAIN |
| AGILYSYS, INC. | September 4, 2025 | Election of Directors: Melvin L. Keating Director Elections |
Board | For | FOR 7 funds |
Split 5 FOR, 1 ABSTAIN |
| AGILYSYS, INC. | September 4, 2025 | Election of Directors: Michael A. Kaufman Director Elections |
Board | For | FOR 7 funds |
Split 5 FOR, 1 ABSTAIN |
| AGILYSYS, INC. | September 4, 2025 | Election of Directors: Ramesh Srinivasan Director Elections |
Board | For | FOR 7 funds |
Split 5 FOR, 1 ABSTAIN |
| AGILYSYS, INC. | September 4, 2025 | Ratification of the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending March 31, 2026 Audit-related |
Board | For | FOR 7 funds |
Split 5 FOR, 1 ABSTAIN |
| AGIOS PHARMACEUTICALS, INC. | June 18, 2026 | To approve an amendment to the Agios Pharmaceuticals, Inc. 2023 Stock Incentive Plan, as Amended, to increase the number of shares of common stock available thereunder by 2,000,000 shares. Compensation |
Board | For | FOR 4 funds |
Split 2 FOR, 1 ABSTAIN |
| AGIOS PHARMACEUTICALS, INC. | June 18, 2026 | To elect each of the three Class I director nominees set forth in the Proxy Statement, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her respective successor is duly elected and qualified. Rahul Ballal, Ph.D. Director Elections |
Board | For | FOR 4 funds |
Split 1 FOR, 1 WITHHOLD |
| AGIOS PHARMACEUTICALS, INC. | June 18, 2026 | To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 4 funds |
Split 2 FOR, 1 ABSTAIN |
| AGIOS PHARMACEUTICALS, INC. | June 18, 2026 | To vote, on an advisory basis, to approve the compensation paid to our named executive officers. Say-on-Pay |
Board | For | AGAINST 8 funds |
Split 2 FOR, 1 ABSTAIN |
| AGREE REALTY CORPORATION | May 14, 2026 | To approve, by non-binding vote, executive compensation. Say-on-Pay |
Board | For | FOR 14 funds |
Split 3 FOR, 1 AGAINST, 2 ABSTAIN |
| AGREE REALTY CORPORATION | May 14, 2026 | To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for 2026. Audit-related |
Board | For | FOR 7 funds |
Split 4 FOR, 2 ABSTAIN |
| AIR LEASE CORPORATION | December 18, 2025 | Proposal to approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to the named executive officers of Air Lease Corporation in connection with the merger (the ''Compensation Proposal''). Say-on-Pay |
Board | For | FOR 13 funds |
Split 2 FOR, 2 ABSTAIN |
| AIR PRODUCTS AND CHEMICALS, INC. | January 28, 2026 | Advisory vote approving the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 36 funds |
Split 5 FOR, 1 ABSTAIN |
| AIR PRODUCTS AND CHEMICALS, INC. | January 28, 2026 | Ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending September 30, 2026. Audit-related |
Board | For | FOR 27 funds |
Split 5 FOR, 1 ABSTAIN |
| AIRBNB INC | June 5, 2026 | To approve, on an advisory (non-binding) basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 44 funds |
Split 6 FOR, 2 AGAINST, 3 ABSTAIN |
| AIRBNB INC | June 5, 2026 | To elect Nathan Blecharczyk, Alfred Lin and James Manyika as Class III Directors to serve until the 2029 Annual Meeting of Stockholders, and until their respective successors are duly elected and qualified: Nathan Blecharczyk. Director Elections |
Board | For | FOR 33 funds |
Split 1 FOR, 4 WITHHOLD |
| AIRBNB INC | June 5, 2026 | To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 33 funds |
Split 8 FOR, 3 ABSTAIN |
| AKAMAI TECHNOLOGIES, INC. | May 13, 2026 | Election of Directors: Bas Burger Director Elections |
Board | For | FOR 23 funds |
Split 5 FOR, 2 ABSTAIN |
| AKAMAI TECHNOLOGIES, INC. | May 13, 2026 | Election of Directors: Dan Hesse Director Elections |
Board | For | FOR 23 funds |
Split 5 FOR, 2 ABSTAIN |
| AKAMAI TECHNOLOGIES, INC. | May 13, 2026 | Election of Directors: Janaki Akella Director Elections |
Board | For | FOR 23 funds |
Split 4 FOR, 1 AGAINST, 2 ABSTAIN |
| AKAMAI TECHNOLOGIES, INC. | May 13, 2026 | Election of Directors: Jonathan Miller Director Elections |
Board | For | FOR 23 funds |
Split 5 FOR, 2 ABSTAIN |
| AKAMAI TECHNOLOGIES, INC. | May 13, 2026 | Election of Directors: Madhu Ranganathan Director Elections |
Board | For | FOR 23 funds |
Split 5 FOR, 2 ABSTAIN |
| AKAMAI TECHNOLOGIES, INC. | May 13, 2026 | Election of Directors: Marianne Brown Director Elections |
Board | For | FOR 23 funds |
Split 5 FOR, 2 ABSTAIN |
| AKAMAI TECHNOLOGIES, INC. | May 13, 2026 | Election of Directors: Sharon Bowen Director Elections |
Board | For | FOR 23 funds |
Split 5 FOR, 2 ABSTAIN |
| AKAMAI TECHNOLOGIES, INC. | May 13, 2026 | Election of Directors: Tom Killalea Director Elections |
Board | For | FOR 23 funds |
Split 4 FOR, 2 ABSTAIN |
| AKAMAI TECHNOLOGIES, INC. | May 13, 2026 | Election of Directors: Tom Leighton Director Elections |
Board | For | FOR 23 funds |
Split 5 FOR, 2 ABSTAIN |
| AKAMAI TECHNOLOGIES, INC. | May 13, 2026 | To approve an amendment to our Second Amended and Restated 2013 Stock Incentive Plan to increase the number of shares of common stock authorized for issuance thereunder by 8,000,000 shares. Compensation |
Board | For | FOR 23 funds |
Split 1 FOR, 4 AGAINST, 2 ABSTAIN |
| AKAMAI TECHNOLOGIES, INC. | May 13, 2026 | To approve the Company's 2026 Employee Stock Purchase Plan. Compensation |
Board | For | FOR 23 funds |
Split 5 FOR, 2 AGAINST |
| AKAMAI TECHNOLOGIES, INC. | May 13, 2026 | To approve, on an advisory basis, our named executive officer compensation. Say-on-Pay |
Board | For | FOR 33 funds |
Split 5 FOR, 2 ABSTAIN |
| AKAMAI TECHNOLOGIES, INC. | May 13, 2026 | To ratify the selection of PricewaterhouseCoopers LLP as our independent auditors for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 23 funds |
Split 5 FOR, 2 ABSTAIN |
| AKER BP ASA | April 21, 2026 | Approve Creation of Up to NOK 31.6 Million Pool of Capital without Preemptive Rights Capital Structure |
Board | For | AGAINST 4 funds |
Split 1 FOR, 2 AGAINST |
| AKER BP ASA | April 21, 2026 | Authorize Share Repurchase Program and Reissuance of Repurchased Shares Capital Structure |
Board | For | Split 3 FOR, 1 AGAINST |
Split 1 FOR, 2 AGAINST |
| AKER BP ASA | April 21, 2026 | Reelect Charles Ashley Heppenstall as Director Director Elections |
Board | For | AGAINST 4 funds |
Split 1 FOR, 2 AGAINST |
| AKER BP ASA | April 21, 2026 | Reelect Doris Reiter as Director Director Elections |
Board | For | FOR 4 funds |
Split 1 FOR, 2 AGAINST |
| AKER BP ASA | April 21, 2026 | Reelect Oyvind Eriksen (Chair) as Director Director Elections |
Board | For | FOR 4 funds |
Split 1 FOR, 2 AGAINST |
| AKERO THERAPEUTICS, INC | December 2, 2025 | To approve, on an advisory, non-binding basis, the payment of certain compensation that may be paid or become payable by Akero to its named executive officers in connection with the Merger. Say-on-Pay |
Board | Contested | FOR 6 funds |
Split 4 FOR, 1 ABSTAIN |
| AKZO NOBEL NV | April 23, 2026 | Approve Supplement to Remuneration Policy in Respect of M.J. de Vries Compensation |
Board | For | FOR 3 funds |
Split 2 FOR, 3 AGAINST |
| ALAMO GROUP INC. | May 1, 2026 | Proposal FOR approval of the advisory vote on the compensation of the named executive officers. Say-on-Pay |
Board | For | FOR 15 funds |
Split 5 FOR, 1 ABSTAIN |
| ALAMO GROUP INC. | May 1, 2026 | Proposal FOR ratification of the appointment of KPMG LLP as the Company's Independent Auditors for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 10 funds |
Split 5 FOR, 1 ABSTAIN |
| ALARM.COM HOLDINGS, INC. | June 3, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | FOR 11 funds |
Split 4 FOR, 1 ABSTAIN |
| ALARM.COM HOLDINGS, INC. | June 3, 2026 | To ratify the selection by the Audit Committee of the Board of Directors of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 7 funds |
Split 4 FOR, 1 ABSTAIN |
| ALASKA AIR GROUP, INC. | May 12, 2026 | Ratification of the appointment of KPMG LLP as the Company's independent registered public accountants for fiscal year 2026. Audit-related |
Board | For | FOR 7 funds |
Split 3 FOR, 2 ABSTAIN |
| ALBEMARLE CORPORATION | May 5, 2026 | Advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 27 funds |
Split 3 FOR, 3 ABSTAIN |
| ALBEMARLE CORPORATION | May 5, 2026 | Election of the ten nominees named below to the Board of Directors to serve for the ensuing year or until their successors are duly elected and qualified. M. Lauren Brlas Director Elections |
Board | For | FOR 19 funds |
Split 3 FOR, 3 ABSTAIN |
| ALBEMARLE CORPORATION | May 5, 2026 | Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 19 funds |
Split 3 FOR, 3 ABSTAIN |
| ALBERTSONS COMPANIES, INC. | August 7, 2025 | Hold the annual, non-binding, advisory vote on our executive compensation program. Say-on-Pay |
Board | For | FOR 14 funds |
Split 2 FOR, 2 ABSTAIN |
| ALCOA CORPORATION | May 6, 2026 | Approval of the Alcoa Corporation Stock and Incentive Compensation Plan (as Amended and Restated) Compensation |
Board | For | FOR 9 funds |
Split 3 FOR, 5 ABSTAIN |
| ALCOA CORPORATION | May 6, 2026 | Approval, on an advisory basis, of the Company's 2025 named executive officer compensation Say-on-Pay |
Board | For | FOR 15 funds |
Split 3 FOR, 5 ABSTAIN |
| ALCOA CORPORATION | May 6, 2026 | Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent auditor for 2026 Audit-related |
Board | For | FOR 9 funds |
Split 3 FOR, 5 ABSTAIN |
| ALEXANDRIA REAL ESTATE EQUITIES, INC. | May 13, 2026 | To cast a non-binding, advisory vote on a resolution to approve the compensation of the Company's named executive officers, as more particularly described in the accompanying Proxy Statement. Say-on-Pay |
Board | For | FOR 29 funds |
Split 3 FOR, 1 ABSTAIN |
| ALEXANDRIA REAL ESTATE EQUITIES, INC. | May 13, 2026 | To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accountants for the fiscal year ending December 31, 2026, as more particularly described in the accompanying Proxy Statement. Audit-related |
Board | For | FOR 19 funds |
Split 3 FOR, 1 ABSTAIN |
| ALIGN TECHNOLOGY, INC. | May 20, 2026 | Advisory Vote to Approve the Compensation of our Named Executive Officers Say-on-Pay |
Board | For | FOR 21 funds |
Split 5 FOR, 4 ABSTAIN |
| ALIGN TECHNOLOGY, INC. | May 20, 2026 | ELECTION OF DIRECTORS: Andrea L. Saia Director Elections |
Board | For | FOR 15 funds |
Split 5 FOR, 4 ABSTAIN |
| ALIGN TECHNOLOGY, INC. | May 20, 2026 | ELECTION OF DIRECTORS: Anne M. Myong Director Elections |
Board | For | FOR 15 funds |
Split 5 FOR, 4 ABSTAIN |
| ALIGN TECHNOLOGY, INC. | May 20, 2026 | ELECTION OF DIRECTORS: Britt Vitalone Director Elections |
Board | For | FOR 15 funds |
Split 5 FOR, 4 ABSTAIN |
| ALIGN TECHNOLOGY, INC. | May 20, 2026 | ELECTION OF DIRECTORS: C. Raymond Larkin, Jr. Director Elections |
Board | For | FOR 15 funds |
Split 5 FOR, 4 ABSTAIN |
| ALIGN TECHNOLOGY, INC. | May 20, 2026 | ELECTION OF DIRECTORS: Joseph Lacob Director Elections |
Board | For | FOR 15 funds |
Split 5 FOR, 4 ABSTAIN |
| ALIGN TECHNOLOGY, INC. | May 20, 2026 | ELECTION OF DIRECTORS: Joseph M. Hogan Director Elections |
Board | For | FOR 15 funds |
Split 5 FOR, 4 ABSTAIN |
| ALIGN TECHNOLOGY, INC. | May 20, 2026 | ELECTION OF DIRECTORS: Kevin J. Dallas Director Elections |
Board | For | FOR 15 funds |
Split 5 FOR, 4 ABSTAIN |
| ALIGN TECHNOLOGY, INC. | May 20, 2026 | ELECTION OF DIRECTORS: Kevin T. Conroy Director Elections |
Board | For | FOR 15 funds |
Split 5 FOR, 4 ABSTAIN |
| ALIGN TECHNOLOGY, INC. | May 20, 2026 | ELECTION OF DIRECTORS: Mojdeh Poul Director Elections |
Board | For | FOR 15 funds |
Split 5 FOR, 4 ABSTAIN |
| ALIGN TECHNOLOGY, INC. | May 20, 2026 | ELECTION OF DIRECTORS: Susan E. Siegel Director Elections |
Board | For | FOR 15 funds |
Split 5 FOR, 4 ABSTAIN |
| ALIGN TECHNOLOGY, INC. | May 20, 2026 | Ratification of Appointment of Independent Registered Public Accounting Firm Audit-related |
Board | For | FOR 15 funds |
Split 5 FOR, 4 ABSTAIN |
| ALIMENTATION COUCHE-TARD INC | September 3, 2025 | ELECTION OF DIRECTOR: MELANIE KAU Director Elections |
Board | For | FOR 6 funds |
Split 1 FOR, 1 WITHHOLD |
| ALK-ABELLO A/S | March 16, 2026 | APPROVE REMUNERATION POLICY Say-on-Pay |
Board | For | Split 2 FOR, 1 AGAINST |
AGAINST 1 fund |
| ALK-ABELLO A/S | March 16, 2026 | APPROVE REMUNERATION REPORT (ADVISORY VOTE) Say-on-Pay |
Board | For | Split 2 FOR, 1 AGAINST |
AGAINST 1 fund |
| ALK-ABELLO A/S | March 16, 2026 | REELECT LARS HOLMQVIST AS DIRECTOR Director Elections |
Board | For | Split 2 FOR, 1 ABSTAIN |
FOR 1 fund |
| ALK-ABELLO A/S | March 16, 2026 | REELECT LENE SKOLE (VICE CHAIR) AS DIRECTOR Director Elections |
Board | For | Split 2 FOR, 1 ABSTAIN |
ABSTAIN 1 fund |
| ALKAMI TECHNOLOGY INC | May 19, 2026 | To approve, on a non-binding advisory basis, the compensation of our named executive officers, or NEOs. Say-on-Pay |
Board | For | AGAINST 5 funds |
Split 1 FOR, 1 ABSTAIN |
| ALKAMI TECHNOLOGY INC | May 19, 2026 | To ratify the appointment by the Audit Committee of our Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 2 funds |
Split 1 FOR, 1 ABSTAIN |
| ALKERMES PLC | May 20, 2026 | To approve the Alkermes plc 2018 Stock Option and Incentive Plan, as amended. Compensation |
Board | For | FOR 10 funds |
Split 7 FOR, 2 ABSTAIN |
| ALKERMES PLC | May 20, 2026 | To approve, in a non-binding, advisory vote, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 15 funds |
Split 7 FOR, 2 ABSTAIN |
| ALKERMES PLC | May 20, 2026 | To ratify, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the independent auditor and accounting firm of the Company and to authorize, in a binding vote, the Audit and Risk Committee of the Board to set the independent auditor and accounting firm's remuneration. Audit-related |
Board | For | FOR 10 funds |
Split 7 FOR, 2 ABSTAIN |
| ALKERMES PLC | May 20, 2026 | To renew Board authority to allot and issue shares under Irish law. Capital Structure |
Board | For | FOR 10 funds |
Split 7 FOR, 2 AGAINST |
| ALKERMES PLC | May 20, 2026 | To renew Board authority to disapply the statutory pre-emption rights that would otherwise apply under Irish law. Capital Structure |
Board | For | FOR 10 funds |
Split 7 FOR, 2 AGAINST |
| ALLEGION PLC | June 4, 2026 | Approve the compensation of our named executive officers on an advisory (non-binding) basis. Say-on-Pay |
Board | For | FOR 31 funds |
Split 5 FOR, 1 AGAINST, 3 ABSTAIN |
| ALLEGION PLC | June 4, 2026 | Ratify the appointment of our independent registered public accounting firm and authorize the Audit and Finance Committee of the Board of Directors to set the independent registered public accounting firm's remuneration for the fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 21 funds |
Split 6 FOR, 3 ABSTAIN |
| ALLEGRO MICROSYSTEMS, INC. | August 7, 2025 | To approve, on an advisory basis, the Company's executive compensation. Say-on-Pay |
Board | For | FOR 16 funds |
Split 3 FOR, 2 ABSTAIN |
| ALLEGRO MICROSYSTEMS, INC. | August 7, 2025 | To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending March 27, 2026. Audit-related |
Board | For | FOR 11 funds |
Split 3 FOR, 2 ABSTAIN |
| ALLIANT ENERGY CORPORATION | May 20, 2026 | Advisory vote to approve the compensation of our named executive officers Say-on-Pay |
Board | For | FOR 30 funds |
Split 7 FOR, 2 ABSTAIN |
| ALLIANT ENERGY CORPORATION | May 20, 2026 | Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for 2026 Audit-related |
Board | For | FOR 21 funds |
Split 7 FOR, 2 ABSTAIN |
| ALLISON TRANSMISSION HOLDINGS, INC. | May 6, 2026 | An advisory non-binding vote to approve the compensation paid to our named executive officers. Say-on-Pay |
Board | For | AGAINST 14 funds |
Split 4 FOR, 1 ABSTAIN |
| ALLISON TRANSMISSION HOLDINGS, INC. | May 6, 2026 | To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2026. Audit-related |
Board | For | FOR 7 funds |
Split 4 FOR, 1 ABSTAIN |
| ALLOGENE THERAPEUTICS, INC. | June 18, 2026 | To approve an amendment to the Company's Certificate of Incorporation to increase the number of authorized shares of common stock from 400,000,000 shares to 800,000,000 shares. Capital Structure |
Board | For | FOR 3 funds |
Split 2 FOR, 1 AGAINST |
| ALLOGENE THERAPEUTICS, INC. | June 18, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. Say-on-Pay |
Board | For | AGAINST 5 funds |
Split 1 FOR, 1 AGAINST, 1 ABSTAIN |
| ALLOGENE THERAPEUTICS, INC. | June 18, 2026 | To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2026. Audit-related |
Board | For | FOR 3 funds |
Split 2 FOR, 1 ABSTAIN |
| ALLY FINANCIAL INC. | May 6, 2026 | Approval of the Ally Financial Inc. Employee Stock Purchase Plan. Compensation |
Board | For | FOR 7 funds |
Split 4 FOR, 3 AGAINST |
| ALLY FINANCIAL INC. | May 6, 2026 | Approval of the Ally Financial Inc. Incentive Compensation Omnibus Plan. Compensation |
Board | For | FOR 7 funds |
Split 4 FOR, 3 ABSTAIN |
| ALLY FINANCIAL INC. | May 6, 2026 | Ratification of the Audit Committee's engagement of Deloitte & Touche LLP as the Company's independent registered public accounting firm for 2026. Audit-related |
Board | For | FOR 7 funds |
Split 4 FOR, 3 ABSTAIN |
| ALNYLAM PHARMACEUTICALS, INC. | May 20, 2026 | To approve, in a non-binding advisory vote, the compensation of Alnylam's named executive officers. Say-on-Pay |
Board | For | Split 17 FOR, 14 AGAINST |
Split 6 FOR, 4 ABSTAIN |
| ALNYLAM PHARMACEUTICALS, INC. | May 20, 2026 | To elect the following nominees as Class I directors of Alnylam: Elliott Sigal, M.D., Ph.D. Director Elections |
Board | For | FOR 23 funds |
Split 2 FOR, 1 AGAINST |
| ALNYLAM PHARMACEUTICALS, INC. | May 20, 2026 | To elect the following nominees as Class I directors of Alnylam: Stuart A. Arbuckle Director Elections |
Board | For | FOR 23 funds |
Split 2 FOR, 1 AGAINST |
← Previous Page 3 of 105 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 18, 2026 from SEC Form N-PX filings.